Startseite
Reels
Gruppen
Seiten
Mehr sehen
Gruppen Seiten Veranstaltungen Blogs Spendenaufruf
Anmelden Registrieren
Nachtmodus
Targeted Therapy and the NSCLC Market: Matching Drugs to Mutations
Targeted therapies have transformed outcomes for subsets of NSCLC patients — and they are a major growth driver within the non-small cell lung cancer market. By matching drugs to specific genetic alterations, targeted therapy offers higher response rates and better tolerability than traditional chemotherapy for patients whose tumours carry actionable mutations. Key targets include EGFR,...
0 Kommentare ·0 Geteilt ·23 Ansichten ·0 Bewertungen
Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!